Amwill Health Care Ltd vs Medicamen Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of Amwill Health Care Ltd is ₹ 32.3 as of 15 May 15:30 . The P/E Ratio of Amwill Health Care Ltd is 0 as of March 2024 .The P/E Ratio of Medicamen Organics Ltd is 0 as of March 2024 . The Market Cap of Amwill Health Care Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Medicamen Organics Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Amwill Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Medicamen Organics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Amwill Health Care Ltd

Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name Amwill Health Care Private Limited', dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore.
Further, Company was converted into a Public Limited Company and a fresh Certificate of Incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore with the change in name to Amwill Health Care Limited'. Amwill Health Care is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled in developing capabilities, in manufacturing, packaging and distribution.
Since inception, the focus has been on developing formulations which offer solutions to various dermatological disorders.

About Medicamen Organics Ltd

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
The product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

FAQs for the comparison of Amwill Health Care Ltd and Medicamen Organics Ltd

Which company has a larger market capitalization, Amwill Health Care Ltd or Medicamen Organics Ltd?

Market cap of Amwill Health Care Ltd is 64 Cr while Market cap of Medicamen Organics Ltd is 30 Cr

What are the key factors driving the stock performance of Amwill Health Care Ltd and Medicamen Organics Ltd?

The stock performance of Amwill Health Care Ltd and Medicamen Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amwill Health Care Ltd and Medicamen Organics Ltd?

As of May 17, 2026, the Amwill Health Care Ltd stock price is INR ₹32.3. On the other hand, Medicamen Organics Ltd stock price is INR ₹26.0.

How do dividend payouts of Amwill Health Care Ltd and Medicamen Organics Ltd compare?

To compare the dividend payouts of Amwill Health Care Ltd and Medicamen Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.